Strid Group, LLC Sarepta Therapeutics, Inc. Transaction History

Strid Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 20, 2018	SELL	$54.02 - $82.27 $372,738 - $567,663	-6,900 Closed	0 $0
Q4 2017 Jan 23, 2018	SELL	$47.64 - $56.75 $4,764 - $5,675	-100 Reduced 1.43%	6,900 $384,000
Q3 2017 Nov 09, 2017	BUY	$35.73 - $47.15 $14,291 - $18,860	400 Added 6.06%	7,000 $318,000
Q2 2017 Aug 09, 2017	BUY	N/A	6,600	6,600 $222,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Strid Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Strid Group, LLC with notifications on news.